Human Centric Drug Discovery

Drug discovery

Human Centric Drug Discovery helps patients with central nervous disorders by making it easier to develop drugs for their diseases. HCDD uses a unique combination of human data from electronic health records, human-derived stem cell models, and human genomic sequencing to show which drug targets and drugs are more likely to work.

Focus: CNS discovery platform 

Team: James Peach (CEO)Caleb Webber (CTO)Zam Cader (CSO)


Find out more about becoming one of our occupiers and all of the benefits of being at SBC. Contact us today.

Get in touch

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.